NASODINE Trademark

Trademark Overview

On Tuesday, July 14, 2020, a trademark application was filed for NASODINE with the United States Patent and Trademark Office. The USPTO has given the NASODINE trademark a serial number of 79291643. The federal status of this trademark filing is REGISTERED as of Tuesday, March 30, 2021. This trademark is owned by Firebrick Pharma Pty Ltd. The NASODINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for nasal use; pharmaceutical preparations for the treatment and prevention of infections of the nose and throat; pharmaceutical preparations for the treatment and prevention of viral infections
nasodine

General Information

Serial Number79291643
Word MarkNASODINE
Filing DateTuesday, July 14, 2020
Status700 - REGISTERED
Status DateTuesday, March 30, 2021
Registration Number6303444
Registration DateTuesday, March 30, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for nasal use; pharmaceutical preparations for the treatment and prevention of infections of the nose and throat; pharmaceutical preparations for the treatment and prevention of viral infections

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFirebrick Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type82 - NOT AVAILABLE
AddressAU
Party NameFirebrick Pharma Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type82 - NOT AVAILABLE
AddressAU
Party NameFirebrick Pharma Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Trademark Events

Event DateEvent Description
Sunday, August 1, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 8, 2021FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 8, 2021FINAL DISPOSITION PROCESSED
Wednesday, June 30, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, May 10, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, March 30, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Monday, January 11, 2021NOTIFICATION PROCESSED BY IB
Wednesday, December 23, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 23, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 12, 2020REFUSAL PROCESSED BY IB
Thursday, December 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 7, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 7, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 7, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 7, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 7, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 23, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 23, 2020REFUSAL PROCESSED BY MPU
Thursday, November 5, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 4, 2020NON-FINAL ACTION WRITTEN
Monday, October 26, 2020ASSIGNED TO EXAMINER
Tuesday, August 25, 2020APPLICATION FILING RECEIPT MAILED
Thursday, August 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, August 19, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 13, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

nasodine pharmaceutical preparations infections prevention treatment viral throat nose nasal